AP2014007762A0 - New forms and salts of a dihydropyrrolo[1,2C]imidazolyl aldosterone synthase or aromatase inhibitor - Google Patents

New forms and salts of a dihydropyrrolo[1,2C]imidazolyl aldosterone synthase or aromatase inhibitor

Info

Publication number
AP2014007762A0
AP2014007762A0 AP2014007762A AP2014007762A AP2014007762A0 AP 2014007762 A0 AP2014007762 A0 AP 2014007762A0 AP 2014007762 A AP2014007762 A AP 2014007762A AP 2014007762 A AP2014007762 A AP 2014007762A AP 2014007762 A0 AP2014007762 A0 AP 2014007762A0
Authority
AP
ARIPO
Prior art keywords
dihydropyrrolo
imidazolyl
salts
new forms
aromatase inhibitor
Prior art date
Application number
AP2014007762A
Other languages
English (en)
Inventor
Paul Sutton
Eric Loeser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2014007762(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AP2014007762A0 publication Critical patent/AP2014007762A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AP2014007762A 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2C]imidazolyl aldosterone synthase or aromatase inhibitor AP2014007762A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17
PCT/US2013/021521 WO2013109514A1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (1)

Publication Number Publication Date
AP2014007762A0 true AP2014007762A0 (en) 2014-07-31

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2014007762A AP2014007762A0 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2C]imidazolyl aldosterone synthase or aromatase inhibitor

Country Status (41)

Country Link
US (2) US9334276B2 (es)
EP (1) EP2804863B1 (es)
JP (1) JP5749410B2 (es)
KR (2) KR20140093726A (es)
CN (1) CN104039793B (es)
AP (1) AP2014007762A0 (es)
AR (1) AR089728A1 (es)
AU (1) AU2013209952B2 (es)
BR (1) BR112014017260A8 (es)
CA (1) CA2863339C (es)
CL (1) CL2014001863A1 (es)
CO (1) CO7000775A2 (es)
CR (1) CR20140345A (es)
CU (1) CU20140086A7 (es)
CY (1) CY1117914T1 (es)
DK (1) DK2804863T3 (es)
EA (1) EA026232B1 (es)
ES (1) ES2564143T3 (es)
GT (1) GT201400155A (es)
HK (1) HK1198536A1 (es)
HR (1) HRP20160178T1 (es)
HU (1) HUE026984T2 (es)
IL (1) IL233541B (es)
IN (1) IN2014DN06781A (es)
JO (1) JO3137B1 (es)
MA (1) MA35858B1 (es)
MX (1) MX2014008686A (es)
NZ (1) NZ626277A (es)
PE (1) PE20142358A1 (es)
PH (1) PH12014501638A1 (es)
PL (1) PL2804863T3 (es)
RS (1) RS54589B1 (es)
SG (1) SG11201404061YA (es)
SI (1) SI2804863T1 (es)
SM (1) SMT201600083B (es)
TN (1) TN2014000256A1 (es)
TW (1) TWI609869B (es)
UA (1) UA114803C2 (es)
UY (1) UY34576A (es)
WO (1) WO2013109514A1 (es)
ZA (1) ZA201404314B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5602250B2 (ja) * 2010-01-14 2014-10-08 ノバルティス アーゲー 副腎ホルモン修飾剤の使用
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
EA201991359A1 (ru) * 2014-07-07 2020-03-13 Новартис Аг Фармацевтические лекарственные формы
RS61908B1 (sr) * 2015-01-29 2021-06-30 Recordati Ag Postupak za proizvodnju kondenzovanih imidazolo derivata
US20160287565A1 (en) * 2015-04-06 2016-10-06 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
KR102506380B1 (ko) 2016-10-27 2023-03-03 다미안 파르마 에이쥐 알도스테론 합성효소 저해제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
DK0625155T3 (da) 1992-01-27 2001-11-12 Janssen Pharmaceutica Nv Pyrroloimidazolyl- og imidazopyridinyl-substituerede 1H-benzimidazolderivater som aromataseinhibitorer
ATE398124T1 (de) 2002-11-18 2008-07-15 Novartis Pharma Gmbh Imidazoä1,5üa pyridin-derivate und methoden zur behandlung von krankheiten in verbindung mit aldosteron
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
EP2094669A2 (en) 2006-12-18 2009-09-02 Novartis AG 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
JP5602250B2 (ja) * 2010-01-14 2014-10-08 ノバルティス アーゲー 副腎ホルモン修飾剤の使用

Also Published As

Publication number Publication date
SI2804863T1 (sl) 2016-05-31
TWI609869B (zh) 2018-01-01
HK1198536A1 (en) 2015-05-15
PL2804863T3 (pl) 2016-06-30
CO7000775A2 (es) 2014-07-21
PE20142358A1 (es) 2015-01-30
CA2863339C (en) 2021-03-23
CY1117914T1 (el) 2017-05-17
ES2564143T3 (es) 2016-03-18
EP2804863B1 (en) 2015-12-02
GT201400155A (es) 2017-09-28
DK2804863T3 (en) 2016-03-07
MX2014008686A (es) 2014-08-27
BR112014017260A2 (pt) 2017-06-13
ZA201404314B (en) 2015-08-26
EA026232B1 (ru) 2017-03-31
SG11201404061YA (en) 2014-08-28
AU2013209952B2 (en) 2016-09-01
AR089728A1 (es) 2014-09-10
UA114803C2 (uk) 2017-08-10
HRP20160178T1 (hr) 2016-03-25
HUE026984T2 (en) 2016-08-29
SMT201600083B (it) 2016-04-29
JP5749410B2 (ja) 2015-07-15
IL233541B (en) 2018-12-31
IL233541A0 (en) 2014-08-31
ES2564143T8 (es) 2020-11-18
AU2013209952A1 (en) 2014-07-24
NZ626277A (en) 2015-10-30
RS54589B1 (en) 2016-08-31
TW201335161A (zh) 2013-09-01
BR112014017260A8 (pt) 2017-07-04
EA201491374A1 (ru) 2014-12-30
CA2863339A1 (en) 2013-07-25
CN104039793A (zh) 2014-09-10
TN2014000256A1 (en) 2015-09-30
CU20140086A7 (es) 2014-12-26
PH12014501638B1 (en) 2014-10-13
KR20140093726A (ko) 2014-07-28
CN104039793B (zh) 2017-05-10
UY34576A (es) 2013-09-02
CR20140345A (es) 2014-09-09
WO2013109514A1 (en) 2013-07-25
IN2014DN06781A (es) 2015-05-22
MA35858B1 (fr) 2014-12-01
JO3137B1 (ar) 2017-09-20
CL2014001863A1 (es) 2014-11-07
KR20140141687A (ko) 2014-12-10
PH12014501638A1 (en) 2014-10-13
US20140364470A1 (en) 2014-12-11
EP2804863A1 (en) 2014-11-26
US20160176883A1 (en) 2016-06-23
US9334276B2 (en) 2016-05-10
JP2015503627A (ja) 2015-02-02

Similar Documents

Publication Publication Date Title
HK1254345B (zh) Cdk抑制劑
HK1209632A1 (en) Irak inhibitors and uses thereof -1 (irak)
EP2637502A4 (en) MUTANT-SELECTIVE EGFR HEMMER AND USES THEREOF
HK1202333A1 (en) Combination of kinase inhibitors and uses thereof
GB201016880D0 (en) Phosphodiesterase inhibitors
GB201009731D0 (en) Kinase inhibitors
IL233541A0 (en) Salts and forms of dihydropyrrolo[1,2-c] imidazole aldosterone synthase or aromatase inhibitor
HRP20160735T1 (hr) Derivati tetrahidro-kinazolinona kao inhibitori tank i parp
ZA201206456B (en) Uses of dgati inhibitors
EP2701512A4 (en) INHIBITORS OF ALDOSTERONE SYNTHASE
ZA201300036B (en) Banzamide derivatives and their use as hsp90 inhibitors
EP2688901A4 (en) INHIBITORS OF 17SS-HSD1, 17SS-HSD3 AND 17SS-HSD10
GB201020798D0 (en) Corrosion inhibitors
EP2861071A4 (en) ALDOSTERONSYNTHASEHEMMER
GB201219678D0 (en) Ketone body inhibitors and uses thereof
HRP20150939T1 (en) Pyrazole derivatives useful as aldosterone synthase inhibitors